ASS1 and colorectal carcinoma: This fully aligns with our observation that the expression of ASS1 shows a simultaneous decrease following EVO-mediated downregulation of c-MYC, further confirming that EVO inhibits the transcriptional activation and protein expression of ASS1 in CRC by suppressing the Wnt/β-catenin/c-MYC axis.